Alberto Durazo

I am a physician scientists working on immunooncology of neurotumors at the Sonora Cancer Research Center

[Kristel Gonzalez @Kristel_GT]

@AbiossS @jamatute78 @JorgeC_CICS @leoalexrangel @DrJorgeCarlosG1 @dias_siete @DurazoAlberto @CicsAngeles @olgar_b @sergiogdealba @rosascorp Thanks Dr. Marquez @AbiossS for the tweet. We really need to start specific #Cancer treatment for our population in #Mexico . #Cancer is a heterogeneous disease. #Genetic background is the most important issue.

[Alberto Durazo @DurazoAlberto]

@AbiossS @2019Allergy @jamatute78 @rosascorp @DrJorgeCarlosG1 @JorgeC_CICS @ItziaCICS @leoalexrangel We will have an amazing data base to do research with and share what I’m sure will be great clinical relevant findings

[El Siete Dias @dias_siete]

@AbiossS @letswinpc @OncologyCentral @sergiogdealba @Mummymegan @Lizbellones @lupitahumildad @nicholasbeaty @DurazoAlberto @DrJorgeCarlosG1 @karlaramirezb @rosascorp Excelente Let’s integrate the clinical oncology care for the prosperity of the world and less suffering by cancer. @dias_siete @OncologyCentral @sergiogdealba @Mummymegan @Lizbellones @lupitahumildad @nicholasbeaty @DurazoAlberto @DrJorgeCarlosG1 @karlaramirezb @rosascorp

[ESMO - Eur. Oncology @myESMO]

New ESMO webinar series - still time to register (freely available to all ESMO members) - 'Translating immunity to clinical applications of #immunotherapy in #breastcancer.' 3/5 at #ESMOBreast19

[gilberto lopes @GlopesMd]

Do you follow @JGO_ASCO ? If not, click on our twitter handle and join us!!! RTs are welcome too @ASCO @myEsmo @UICC @SylvesterCancer @OphiraG @oncology_bg @EnriqueSoto8 @montypal @weoncologists @GilbertodeCas13 @univmiami @JackWestMD @chadinabhan

[Dr. Jan Nolta @jan_nolta]

Great to speak in the Trainee Session at the 26th Annual Conference of the American Society for #Neural Therapy and Repair, with Dr. James Kovach and Dr. Wang ⁦@aijunw⁩ of #UCDavis, Dr. Robert Mays of ⁦@Athersyss⁩, hosted by Dr. Kyle Fink ⁦@FinkLab #ASNTR2019 🧠

[Puma58 @sergioalej07]

Será que luego lo van a invitar a asesorar al nuevo gobierno de México? Cada vez las cosas apuntan a un grave autoritarismo, lo que no debemos aceptar, sobretodo por las nuevas generaciones. Nosotros ya vivimos los excesos de Díaz Ordaz, LEA JOLOPO y CSG

[gilberto lopes @GlopesMd]

"With an additional 6 mo follow-up, pembro demonstrated continued OS benefit vs chemo as first-line therapy in pts with locally advanced/metastatic PD-L1–positive NSCLC without EGFR/ALK alterations."
@TonyMok9 presented @myESMO #ELCC19
https://t.co/gn4E9hgzjY

[Oncology Central @OncologyCentral]

Researchers have used #organoids to demonstrate how cancers are able to hide from cibisatamab, a promising #immunotherapy. Find out more by clicking the image below: https://t.co/mYrM3jos2l

[Suzie Siegel @SuzieSiegel]

I went into the ER yesterday, and this was written on the door of my room. #MRSA

[@CICS MD JP @JPMM_MD_CICS]

Let’s prevent relapse, cancer is never gone unless you have a clinically cocktail of drugs for relapse prevention. The binational immunooncology alliance from Seattle & Sonora the only place in the world with the cancer relapse prevention clinic: clinical facts not words.

[@CICS MD JP @JPMM_MD_CICS]

https://t.co/EQqGZvrskz. Let’s link the ribbons to STOP cancer, many years & a lot of wasted funding but few clinical facts. Why? Ideas are welcome. Is the clinical oncology & cancer research obsolete? Is time to rethink about these topics in order to have zero or less suffering

[@CICS MD JP @JPMM_MD_CICS]

Yo espero tener a Sonora como país. Mexico personalmente aún, cuando sonora es aún parte de el, siento que con todo el respeto que Mexico merece,sonora merece ser un país digno y recuerden que de aquí salió la única actriz MF que dijo “no te equivoques en Sonora nace la belleza”

[@CICS MD JP @JPMM_MD_CICS]

In case you like to help this wonderful 20 years old with refractory sarcoma. Now the tumor is responding very well to the multi peptide immunotherapy + immunogenic chemotherapy + cytokine immunomodulation + Repurposing Drugs + tumor microenvironment immunomodulation

[Society for Immunotherapy of Cancer @sitcancer]

#JITC Commentary: Comparative analysis of the phase III clinical trials of anti-PD1 monotherapy in head and neck squamous cell carcinoma patients (CheckMate 141 and KEYNOTE 040) https://t.co/TYbvYcb4xU

[ASCO @ASCO]

The number of electronic health record systems joining with #CancerLinQ to facilitate information sharing continues to grow https://t.co/FsEmqIPHsm #ASCOconnection

[Society for Immunotherapy of Cancer @sitcancer]

In his April President’s Message, SITC President Dr. Mario Sznol discusses the 34th Annual Meeting & Pre-Conference Programs (#SITC2019), the 2019 interim workshops and Dr. Olivera (Olja) J. Finn as the recipient for the 2019 SITC Smalley Award https://t.co/5nNqqvmuBr

[Juan Felipe Córdoba @juanfecordoba]

Starting #ELCC with this necessary issue: “how to best use ICP in NSCLC: single agents or combo?” @dplanchard @peters_solange #LCSM @myESMO

[Society for Immunotherapy of Cancer @sitcancer]

NEWS RELEASE: Society for Immunotherapy of Cancer Publishes First-of-its-Kind Handbook for Management of Side Effects Associated with Cancer Immunotherapies https://t.co/XaG2DaQyrC

[OncoAlert @OncoAlert]

#OncoAlert #lungcancer #lcsm